Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04464005
Other study ID # 112-19
Secondary ID
Status Recruiting
Phase Phase 4
First received
Last updated
Start date November 15, 2023
Est. completion date December 1, 2024

Study information

Verified date September 2023
Source The Baruch Padeh Medical Center, Poriya
Contact Enav Yefet, MD/PhD
Phone 972-46652306
Email enyefet@pmc.gov.il
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Perineal pain after delivery is common and is caused by local bruising or episiotomy. The pain may last for several days or months. Thus, several analgesic methods are offered. Topical magnesium sulfate 33% solution is a common treatment for perineal pain, wound treatment and alleviation of swelling. Yet, the efficacy of this treatment was not tested sufficiently in a clinical trials. In the present study we will compare the efficacy of topical magnesium sulfate versus cold water for perineal pain and improved perineal healing after delivery. Women after vaginal delivery (spontaneous or operative) with pain score of 3 in 0-10 numeric rating scale (NRS) will randomly be allocated to receive either pad with cold magnesium sulfate 33% solution or cold water. Pain score and healing parameters will be assessed at baseline, after one day of treatment and after two days of treatment.


Recruitment information / eligibility

Status Recruiting
Enrollment 140
Est. completion date December 1, 2024
Est. primary completion date December 1, 2024
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - Woman after spontaneous or operative vaginal delivery - Perineal pain score of at least 2 NRS Exclusion Criteria: - Women after cesarean delivery - Refuse to participate - Under 18 years of age - Magnesium sulfate treatment not related to the study - Contraindication for magnesium sulfate treatment - Workers of the local obstetric department

Study Design


Related Conditions & MeSH terms

  • Women After Delivery With Perineal Pain

Intervention

Drug:
Magnesium sulfate 33% solution
Topical pads with cold magnesium sulfate 33% solution will be given 5 times/day for 15 minutes
Other:
Cold water
Topical pads with cold water will be given 5 times/day for 15 minutes

Locations

Country Name City State
Israel Baruch Padeh Medical center, Poriya Tiberias North

Sponsors (1)

Lead Sponsor Collaborator
The Baruch Padeh Medical Center, Poriya

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary Rate of women with perineal pain score< 3 NRS at the day after treatment initiation 24 hours post enrollment
Primary Perineal pain intensity according to NRS scale at the day after treatment initiation 24 hours post enrollment
Secondary Degree of perineal healing using the REEDA scale 2 days
Secondary Perineal pain intensity according to NRS scale two days after treatment initiation 2 days (if still in hospital)
Secondary Rate of women with improvement in hemorrhoids characteristics in women with hemorrhoids 2 days